Skip to content
OpenCapital
Get started

MIRA Pharmaceuticals, Inc. MIRA Q4 2024 Annual earnings

Reported March 28, 2025 · Before market open

Revenue$11.2M
EPS-$0.15Beat by $0.14
EPS estimate-$0.29

Next report

Sep 2, 2026 (in a month)

Versus estimates

Revenue

Q4 2024$11.2M

Diluted EPS

Q1 2026-$0.03Q4 2025-$0.15Miss by $0.11Q3 2025-$1.18In lineQ2 2025-$0.09Beat by $0.02Q1 2025-$0.11Beat by $0.04
Q4 2024-$0.15Beat by $0.14

Ask the moment MIRA Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did MIRA Pharmaceuticals, Inc. report Q4 2024 earnings?
MIRA Pharmaceuticals, Inc. (MIRA) reported Q4 2024 earnings on March 28, 2025 before market open.
What were MIRA Pharmaceuticals, Inc.'s Q4 2024 revenue and EPS?
MIRA Pharmaceuticals, Inc. reported revenue of $11.2M and eps of $-0.15 for Q4 2024.
Did MIRA Pharmaceuticals, Inc. beat estimates in Q4 2024?
EPS beat the consensus estimate of $-0.29 by $0.14.
Where can I find MIRA Pharmaceuticals, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001641172-25-001183) directly on SEC EDGAR. The filing index links above go to sec.gov.